Mapping normal and cancer cell signalling networks: towards single-cell proteomics
- 1 February 2006
- journal article
- innovation
- Published by Springer Science and Business Media LLC in Nature Reviews Cancer
- Vol. 6 (2), 146-155
- https://doi.org/10.1038/nrc1804
Abstract
Oncogenesis and tumour progression are supported by alterations in cell signalling. Using flow cytometry, it is now possible to track and analyse signalling events in individual cancer cells. Data from this type of analysis can be used to create a network map of signalling in each cell and to link specific signalling profiles with clinical outcomes. This form of 'single-cell proteomics' can identify pathways that are activated in therapy-resistant cells and can provide biomarkers for cancer diagnosis and for determining patient prognosis.Keywords
This publication has 85 references indexed in Scilit:
- NF-κB: linking inflammation and immunity to cancer development and progressionNature Reviews Immunology, 2005
- The role of TGF-β and Wnt signaling in gastrointestinal stem cells and cancerOncogene, 2005
- The discovery of receptor tyrosine kinases: targets for cancer therapyNature Reviews Cancer, 2004
- The Three Es of Cancer ImmunoeditingAnnual Review of Immunology, 2004
- The STATs of cancer — new molecular targets come of ageNature Reviews Cancer, 2004
- Targeting RAS signalling pathways in cancer therapyNature Reviews Cancer, 2003
- Mutations of the BRAF gene in human cancerNature, 2002
- Targeting death and decoy receptors of the tumour-necrosis factor superfamilyNature Reviews Cancer, 2002
- Molecular mechanisms underlying ErbB2/HER2 action in breast cancerOncogene, 2000
- The Hallmarks of CancerCell, 2000